Ultragenyx Pharmaceutical, Inc. (RARE)
24.20
+0.32
(+1.34%)
USD |
NASDAQ |
Feb 10, 16:00
24.49
+0.29
(+1.20%)
After-Hours: 07:33
Ultragenyx Pharmaceutical Market Cap : 2.335B for Feb. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 4.310B |
| Johnson & Johnson | 574.26B |
| CorMedix, Inc. | 605.89M |
| Insmed, Inc. | 31.68B |
| Apellis Pharmaceuticals, Inc. | 2.857B |
Market Cap Related Metrics
| PS Ratio | 3.744 |
| Price to Book Value | 254.91 |
| Price | 24.20 |
| Earnings Yield | -24.54% |